WILSON GAYLE E 4
4 · GILEAD SCIENCES INC · Filed Feb 13, 2018
Insider Transaction Report
Form 4
WILSON GAYLE E
Director
Transactions
- Exercise/Conversion
Common Stock
2018-02-09$26.61/sh+60,000$1,596,900→ 182,258 total - Sale
Common Stock
2018-02-09$77.92/sh−60,000$4,675,080→ 122,258 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2018-02-09−60,000→ 0 totalExercise: $26.61Exp: 2018-05-08→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]Sale prices reported for the transactions reported here range from $77.88 to $78.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- [F2]Options vest 100% on the first anniversary date of the grant.